Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting?

SIMPLE SUMMARY: This work aims to discuss how an anti- or pro-tumor immune response could be manipulated through immune checkpoint blockade in patients with early stage HER2-positive breast cancer. By summarizing previously published evidence in the field, authors present their personal view on how...

Descripción completa

Detalles Bibliográficos
Autores principales: Solinas, Cinzia, Fumagalli, Debora, Dieci, Maria Vittoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036848/
https://www.ncbi.nlm.nih.gov/pubmed/33916115
http://dx.doi.org/10.3390/cancers13071655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036848/
https://www.ncbi.nlm.nih.gov/pubmed/33916115
http://dx.doi.org/10.3390/cancers13071655

Ejemplares similares